Skip to main content
SpringerLink
Log in

Cancers of the Larynx: Tis, T1, T2 Evaluation and Management

  • Chapter
  • First Online:
Head and Neck Cancer

Abstract

In the USA, larynx cancer affects an estimated 1 in 250 people. Current treatment modalities emphasize obtaining a cure while maximizing the preservation of function and the quality of life. For early larynx cancers (Tis, T1, T2), these treatment options include primary radiotherapy, transoral endoscopic resection, and conservation laryngeal surgery. Current literature reports similar rates of local control and survival among these modalities, such that management decisions should incorporate the stage, extent of disease, and the anticipated functional outcomes within the context of patient social and medical factors. This chapter discusses the epidemiology, presentation, evaluation, and management of early larynx cancers, with a focus on treatment options and functional considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  2. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116(9 Pt 2 Suppl 111):1–13.

    Article  PubMed  Google Scholar 

  3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.

    Article  PubMed  Google Scholar 

  4. Starmer HM, Tippett DC, Webster KT. Effects of laryngeal cancer on voice and swallowing. Otolaryngol Clin North Am. 2008;41(4):793–818. vii.

    Google Scholar 

  5. Pfister DG, Laurie SA, Weinstein GS, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006;24(22):3693–704.

    Article  PubMed  Google Scholar 

  6. National Comprehensive Cancer Network I. NCCN clinical practice guidelines in oncology: head and neck cancers. 2007 http://www.nccn.org. To view the most recent and complete version of the guideline. www.nccn.org. Accessed 2007.

  7. Mendenhall WM, Riggs CE, Cassisi NJ. Treatment of head and neck cancer. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.

    Google Scholar 

  8. Beitler JJ, Mahadevia PS, Silver CE, et al. New barriers to ventricular invasion in paraglottic laryngeal cancer. Cancer. 1994;73(10):2648–52.

    Article  CAS  PubMed  Google Scholar 

  9. Pressman JJ. Submucosal compartmentation of the larynx. Ann Otol Rhinol Laryngol. 1956;65(3):766–71.

    Article  CAS  PubMed  Google Scholar 

  10. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev. 2006;32(7):504–15.

    Article  PubMed  Google Scholar 

  11. Hicks Jr WL, Kollmorgen DR, Kuriakose MA, et al. Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg. 1999;121(1):57–61.

    Article  PubMed  Google Scholar 

  12. Breau RL, Suen JY. Management of the N(0) neck. Otolaryngol Clin North Am. 1998;31(4):657–69.

    Article  CAS  PubMed  Google Scholar 

  13. Concus AP, Tran TP, Sanfilippo NJ, DeLacure MD. Malignant laryngeal lesions. In: Lalwani AK, editor. Current diagnosis and treatment: otolaryngology head and neck surgery. 2nd ed. New York: McGraw Hill; 2008.

    Google Scholar 

  14. Ferlito A, Rinaldo A. The pathology and management of subglottic cancer. Eur Arch Otorhinolaryngol. 2000;257(3):168–73.

    Article  CAS  PubMed  Google Scholar 

  15. Buckley JG, MacLennan K. Cancer spread in the larynx: a pathologic basis for conservation surgery. Head Neck. 2000;22(3):265–74.

    Article  CAS  PubMed  Google Scholar 

  16. Kirchner JA, Carter D. Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol. 1987;103(5–6):503–13.

    CAS  PubMed  Google Scholar 

  17. Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41(4): 673–95. v.

    Google Scholar 

  18. Sadri M, McMahon J, Parker A. Laryngeal dysplasia: aetiology and molecular biology. J Laryngol Otol. 2006;120(3):170–7.

    Article  PubMed  Google Scholar 

  19. Tuyns AJ, Esteve J, Raymond L, et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer. 1988;41(4):483–91.

    Article  CAS  PubMed  Google Scholar 

  20. Talamini R, Bosetti C, La Vecchia C, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 2002;13(10):957–64.

    Article  CAS  PubMed  Google Scholar 

  21. Bosetti C, Garavello W, Gallus S, La Vecchia C. Effects of smoking cessation on the risk of laryngeal cancer: an overview of published studies. Oral Oncol. 2006;42(9):866–72.

    Article  PubMed  Google Scholar 

  22. Muscat JE, Wynder EL. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer. 1992;69(9):2244–51.

    Article  CAS  PubMed  Google Scholar 

  23. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001;96(7):2013–8.

    Article  CAS  PubMed  Google Scholar 

  24. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope. 2002;112(10):1861–5.

    Article  CAS  PubMed  Google Scholar 

  25. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709–20.

    Article  CAS  PubMed  Google Scholar 

  26. Smith EM, Summersgill KF, Allen J, et al. Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol. 2000;109(11):1069–76.

    Article  CAS  PubMed  Google Scholar 

  27. Gallagher TQ, Derkay CS. Recurrent respiratory papillomatosis: update 2008. Curr Opin Otolaryngol Head Neck Surg. 2008;16(6):536–42.

    Article  PubMed  Google Scholar 

  28. Jeong WJ, Park SW, Shin M, et al. Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis. Head Neck. 2009;31(8):1095–101.

    Article  PubMed  Google Scholar 

  29. Thekdi AA, Ferris RL. Diagnostic assessment of laryngeal cancer. Otolaryngol Clin North Am. 2002;35(5):953–69. v.

    Google Scholar 

  30. Raitiola H, Pukander J. Symptoms of laryngeal carcinoma and their prognostic significance. Acta Oncol. 2000;39(2):213–6.

    Article  CAS  PubMed  Google Scholar 

  31. Postma GN, Bach KK, Belafsky PC, Koufman JA. The role of transnasal esophagoscopy in head and neck oncology. Laryngoscope. 2002;112(12):2242–3.

    Article  PubMed  Google Scholar 

  32. Colden D, Zeitels SM, Hillman RE, Jarboe J, Bunting G, Spanou K. Stroboscopic assessment of vocal fold keratosis and glottic cancer. Ann Otol Rhinol Laryngol. 2001;110(4):293–8.

    Article  CAS  PubMed  Google Scholar 

  33. Ansarin M, Zabrodsky M, Bianchi L, et al. Endoscopic CO2 laser surgery for early glottic cancer in patients who are candidates for radiotherapy: results of a prospective nonrandomized study. Head Neck. 2006;28(2):121–5.

    Article  PubMed  Google Scholar 

  34. Moreau PR. Treatment of laryngeal carcinomas by laser endoscopic microsurgery. Laryngoscope. 2000;110(6):1000–6.

    Article  CAS  PubMed  Google Scholar 

  35. Brunelli A, Al-Refai M, Monteverde M, Borri A, Salati M, Fianchini A. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest. 2002;121(4):1106–10.

    Article  PubMed  Google Scholar 

  36. Thabet HM, Sessions DG, Gado MH, Gnepp DA, Harvey JE, Talaat M. Comparison of clinical evaluation and computed tomographic diagnostic accuracy for tumors of the larynx and hypopharynx. Laryngoscope. 1996;106(5 Pt 1):589–94.

    Article  CAS  PubMed  Google Scholar 

  37. Yousem DM, Gad K, Tufano RP. Resectability issues with head and neck cancer. AJNR Am J Neuroradiol. 2006;27(10):2024–36.

    CAS  PubMed  Google Scholar 

  38. Becker M, Zbaren P, Laeng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology. 1995;194(3):661–9.

    Article  CAS  PubMed  Google Scholar 

  39. Zbaren P, Becker M, Lang H. Pretherapeutic staging of hypopharyngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathologic evaluation. Arch Otolaryngol Head Neck Surg. 1997;123(9):908–13.

    Article  CAS  PubMed  Google Scholar 

  40. Becker M, Zbaren P, Casselman JW, Kohler R, Dulguerov P, Becker CD. Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology. 2008;249(2):551–9.

    Article  PubMed  Google Scholar 

  41. Dullerud R, Johansen JG, Dahl T, Faye-Lund H. Influence of CT on tumor classification of laryngeal carcinomas. Acta Radiol. 1992;33(4):314–8.

    Article  CAS  PubMed  Google Scholar 

  42. Barbera L, Groome PA, Mackillop WJ, et al. The role of computed tomography in the T classification of laryngeal carcinoma. Cancer. 2001;91(2):394–407.

    Article  CAS  PubMed  Google Scholar 

  43. Fleming Jr AJ, Smith Jr SP, Paul CM, et al. Impact of [18F]-2- fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope. 2007;117(7):1173–9.

    Article  PubMed  Google Scholar 

  44. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231(1):65–72.

    Article  PubMed  Google Scholar 

  45. Zanation AM, Sutton DK, Couch ME, Weissler MC, Shockley WW, Shores CG. Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors. Laryngoscope. 2005;115(7):1186–90.

    Article  PubMed  Google Scholar 

  46. Edge SB, Byrd DR, Compton CA, editors. AJCC cancer staging manual. 78th ed. New York, NY: Springer; 2010.

    Google Scholar 

  47. Holsinger FC, Diaz Jr EM. Laryngeal preservation in the era of chemoradiation: limitations of the current AJCC staging system. Head Neck. 2006;28(12):1058–60.

    Article  PubMed  Google Scholar 

  48. Flint PW. Minimally invasive techniques for management of early glottic cancer. Otolaryngol Clin North Am. 2002;35(5):1055–66. vi–vii.

    Google Scholar 

  49. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 2000;46(1):21–6.

    Article  CAS  PubMed  Google Scholar 

  50. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981;305(17):982–7.

    Article  CAS  PubMed  Google Scholar 

  51. Dey P, Arnold D, Wight R, MacKenzie K, Kelly C, Wilson J. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev. 2002;2, CD002027.

    PubMed  Google Scholar 

  52. Hristov B, Bajaj GK. Radiotherapeutic management of laryngeal carcinoma. Otolaryngol Clin North Am. 2008;41(4):715–40. vi.

    Google Scholar 

  53. Mendenhall WM, Parsons JT, Million RR, Fletcher GH. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys. 1988;15(6):1267–73.

    Article  CAS  PubMed  Google Scholar 

  54. Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;39(1):115–26.

    Article  CAS  PubMed  Google Scholar 

  55. Warde P, O’Sullivan B, Bristow RG, et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys. 1998;41(2):347–53.

    Article  CAS  PubMed  Google Scholar 

  56. Marshak G, Brenner B, Shvero J, et al. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys. 1999;43(5):1009–13.

    Article  CAS  PubMed  Google Scholar 

  57. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19(20):4029–36.

    CAS  PubMed  Google Scholar 

  58. Johansen LV, Grau C, Overgaard J. Glottic carcinoma – patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol. 2002;63(3):257–67.

    Article  PubMed  Google Scholar 

  59. Cellai E, Frata P, Magrini SM, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys. 2005;63(5):1378–86.

    Article  PubMed  Google Scholar 

  60. Cheah NL, Lupton S, Marshall A, Hartley A, Glaholm J. Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham experience. Clin Oncol (R Coll Radiol). 2009;21(6):494–501.

    Article  CAS  Google Scholar 

  61. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003;55(2):322–8.

    Article  PubMed  Google Scholar 

  62. Frata P, Cellai E, Magrini SM, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys. 2005;63(5):1387–94.

    Article  PubMed  Google Scholar 

  63. Terhaard CH, Snippe K, Ravasz LA, van der Tweel I, Hordijk GJ. Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys. 1991;21(5):1179–86.

    Article  CAS  PubMed  Google Scholar 

  64. Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck. 1996;18(1):24–35.

    Article  CAS  PubMed  Google Scholar 

  65. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck. 2002;24(5):456–67.

    Article  PubMed  Google Scholar 

  66. Wall TJ, Peters LJ, Brown BW, Oswald MJ, Milas L. Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx. Int J Radiat Oncol Biol Phys. 1985;11(11):1895–902.

    Article  CAS  PubMed  Google Scholar 

  67. Spriano G, Antognoni P, Piantanida R, et al. Conservative management of T1-T2N0 supraglottic cancer: a retrospective study. Am J Otolaryngol. 1997;18(5):299–305.

    Article  CAS  PubMed  Google Scholar 

  68. Jones AS, Fish B, Fenton JE, Husband DJ. The treatment of early laryngeal cancers (T1–T2N0): surgery or irradiation? Head Neck. 2004;26(2):127–35.

    Article  PubMed  Google Scholar 

  69. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8.

    Article  CAS  PubMed  Google Scholar 

  70. Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck. 1999;21(2):116–23.

    Article  CAS  PubMed  Google Scholar 

  71. Spector JG, Sessions DG, Chao KS, et al. Stage I (T1N0M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck. 1999;21(8):707–17.

    Article  CAS  PubMed  Google Scholar 

  72. Schwaibold F, Scariato A, Nunno M, et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys. 1988;14(3):451–4.

    Article  CAS  PubMed  Google Scholar 

  73. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64(1):77–82.

    Article  PubMed  Google Scholar 

  74. Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys. 1993;26(5):767–72.

    Article  CAS  PubMed  Google Scholar 

  75. van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998;42(2):247–55.

    Article  PubMed  Google Scholar 

  76. Trotti III A, Zhang Q, Bentzen SM, et al. Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512). Int J Radiat Oncol Biol Phys. 2014;89(5):958–63.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–39.

    Article  PubMed  Google Scholar 

  78. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 1997;44(2):123–36.

    Article  CAS  PubMed  Google Scholar 

  79. Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 2001;92(11):2892–7.

    Article  CAS  PubMed  Google Scholar 

  80. Glatstein E, Glick J, Kaiser L, Hahn SM. Should randomized clinical trials be required for proton radiotherapy? An alternative view. J Clin Oncol. 2008;26(15):2438–9.

    Article  PubMed  Google Scholar 

  81. Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of clinical experience to date. Int J Radiat Oncol Biol Phys. 2014;89(2):292–302.

    Article  PubMed  Google Scholar 

  82. Ganly I, Patel SG, Matsuo J, et al. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg. 2006;132(1):59–66.

    Article  PubMed  Google Scholar 

  83. Pellini R, Pichi B, Ruscito P, et al. Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck. 2008;30(3):372–9.

    Article  PubMed  Google Scholar 

  84. Rodriguez-Cuevas S, Labastida S, Gonzalez D, Briseno N, Cortes H. Partial laryngectomy as salvage surgery for radiation failures in T1-T2 laryngeal cancer. Head Neck. 1998;20(7):630–3.

    Article  CAS  PubMed  Google Scholar 

  85. Schwaab G, Mamelle G, Lartigau E, Parise Jr O, Wibault P, Luboinski B. Surgical salvage treatment of T1/T2 glottic carcinoma after failure of radiotherapy. Am J Surg. 1994;168(5):474–5.

    Article  CAS  PubMed  Google Scholar 

  86. Steiner W, Vogt P, Ambrosch P, Kron M. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck. 2004;26(6):477–84.

    Article  PubMed  Google Scholar 

  87. Viani L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer. 1991;67(3):577–84.

    Article  CAS  PubMed  Google Scholar 

  88. Holsinger FC, Funk E, Roberts DB, Diaz Jr EM. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck. 2006;28(9):779–84.

    Article  PubMed  Google Scholar 

  89. Laccourreye O, Veivers D, Hans S, Menard M, Brasnu D, Laccourreye H. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1–T4N0M0 complete clinical responders. Cancer. 2001;92(6):1504–11.

    Article  CAS  PubMed  Google Scholar 

  90. Laccourreye O, Weinstein G, Brasnu D, et al. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2. Cancer. 1994;74(10):2781–90.

    Article  CAS  PubMed  Google Scholar 

  91. Laccourreye O, Bassot V, Brasnu D, Laccourreye H. Chemotherapy combined with conservation surgery in the treatment of early larynx cancer. Curr Opin Oncol. 1999;11(3):200–3.

    Article  CAS  PubMed  Google Scholar 

  92. Forastiere AA, Zhang Q, Weber RS, et al. Long term results of RTOG 91-11: a comparison of three non-surgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31(7):845–52.

    Article  CAS  PubMed  Google Scholar 

  93. Posner MR, Norris CM, Wirth LJ, et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery and organ preservation. Ann Oncol. 2009;20(5):921–7.

    Article  CAS  PubMed  Google Scholar 

  94. Nagahashi T, Fukuda S, Homma A, Yagi K, Furuta Y, Inuyama Y. Concurrent chemotherapy and radiotherapy as initial treatment for stage II supraglottic squamous cell carcinoma. Auris Nasus Larynx. 2001;28(Suppl):S95–8.

    Article  PubMed  Google Scholar 

  95. Nishimura G, Tsukuda M, Mikami Y, et al. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation. Anticancer Res. 2009;29(2):661–6.

    PubMed  Google Scholar 

  96. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78.

    Article  CAS  PubMed  Google Scholar 

  97. Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol. 2013;31(7):853–9.

    Article  CAS  PubMed  Google Scholar 

  98. DeSanto LW, Olsen KD. Early glottic cancer. Am J Otolaryngol. 1994;15(4):242–9.

    Article  CAS  PubMed  Google Scholar 

  99. Strong MS, Jako GJ. Laser surgery in the larynx. Early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol. 1972;81(6):791–8.

    CAS  PubMed  Google Scholar 

  100. Jackel MC, Martin A, Steiner W. Twenty-five years experience with laser surgery for head and neck tumors: report of an international symposium, Gottingen, Germany, 2005. Eur Arch Otorhinolaryngol. 2007;264(6):577–85.

    Article  PubMed  Google Scholar 

  101. Genden EM, Ferlito A, Silver CE, et al. Evolution of the management of laryngeal cancer. Oral Oncol. 2007;43(5):431–9.

    Article  PubMed  Google Scholar 

  102. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993;14(2):116–21.

    Article  CAS  PubMed  Google Scholar 

  103. Agrawal N, Ha PK. Management of early-stage laryngeal cancer. Otolaryngol Clin North Am. 2008;41(4):757–69. vi–vii.

    Google Scholar 

  104. Jackel MC, Ambrosch P, Martin A, Steiner W. Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery. Laryngoscope. 2007;117(2):350–6.

    Article  PubMed  Google Scholar 

  105. Eckel HE, Thumfart W, Jungehulsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur Arch Otorhinolaryngol. 2000;257(4):221–6.

    Article  CAS  PubMed  Google Scholar 

  106. Pradhan SA, Pai PS, Neeli SI, D’Cruz AK. Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg. 2003;129(6):623–5.

    Article  PubMed  Google Scholar 

  107. Motta G, Esposito E, Cassiano B. Motta pp. T1–T2-T3 glottic tumors: fifteen years experience with CO2 laser. Acta Otolaryngol Suppl. 1997;527:155–9.

    Article  CAS  PubMed  Google Scholar 

  108. Motta G, Esposito E, Motta S, Tartaro G, Testa D. CO(2) laser surgery in the treatment of glottic cancer. Head Neck. 2005;27(7):566–73. discussion 573–4.

    Article  PubMed  Google Scholar 

  109. Peretti G, Nicolai P, Redaelli De Zinis LO, et al. Endoscopic CO2 laser excision for Tis, T1, and T2 glottic carcinomas: cure rate and prognostic factors. Otolaryngol Head Neck Surg. 2000;123(1 Pt 1):124–31.

    Article  CAS  PubMed  Google Scholar 

  110. Rudert HH, Werner JA. Endoscopic resections of glottic and supraglottic carcinomas with the CO2 laser. Eur Arch Otorhinolaryngol. 1995;252(3):146–8.

    Article  CAS  PubMed  Google Scholar 

  111. Remacle M, Eckel HE, Antonelli A, et al. Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol. 2000;257(4):227–31.

    Article  CAS  PubMed  Google Scholar 

  112. Remacle M, Van Haverbeke C, Eckel H, et al. Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol. 2007;264(5):499–504.

    Article  PubMed  Google Scholar 

  113. Remacle M, Hantzakos A, Eckel H, et al. Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol. 2009;266(7):993–8.

    Article  PubMed  Google Scholar 

  114. Peretti G, Piazza C, Bolzoni A. Endoscopic treatment for early glottic cancer: indications and oncologic outcome. Otolaryngol Clin North Am. 2006;39(1):173–89.

    Article  PubMed  Google Scholar 

  115. Ellies M, Steiner W. Peri- and postoperative complications after laser surgery of tumors of the upper aerodigestive tract. Am J Otolaryngol. 2007;28(3):168–72.

    Article  PubMed  Google Scholar 

  116. Vilaseca-Gonzalez I, Bernal-Sprekelsen M, Blanch-Alejandro JL, Moragas-Lluis M. Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck. 2003;25(5):382–8.

    Article  PubMed  Google Scholar 

  117. Ozer E, Alvarez B, Kakarala K, Durmus K, Teknos TN, Carrau RL. Clinical outcomes of transoral robotic supraglottic laryngectomy. Head Neck. 2013;35(8):1158–61.

    Article  PubMed  Google Scholar 

  118. Ansarin M, Zorzi S, Massaro MA, et al. Transoral robotic surgery vs transoral laser microsurgery for resection of supraglottic cancer: a pilot surgery. Int J Med Robot. 2014;10(1):107–12.

    Article  PubMed  Google Scholar 

  119. Weinstein GS, O’Malley Jr BW, Snyder W, Hockstein NG. Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol. 2007;116(1):19–23.

    Article  PubMed  Google Scholar 

  120. Tufano RP, Laccourreye O, Rassekh C, Weinstein GS. Conservation laryngeal surgery. In: Cummings CW, Flint PW, Harker LA, Haughey BH, Richardson MA, Robbins KT, Schuller DE, Thomas JR, editors. Cummings: otolaryngology head and neck surgery, vol. 3. 4th ed. Philadelphia: Elsevier Mosby; 2005.

    Google Scholar 

  121. Hoffman HT, Karnell LH, McCulloch TM, Bulatti J, Funk G. Management of early glottic cancer. In: Cummings CWFP, Harker LA, Haughey BH, Richardson MA, Robbins KT, Schuller DE, Thomas JR, editors. Cummings: otolaryngology head and neck surgery, vol. 3. 4th ed. Philadelphia: Elsevier Mosby; 2005.

    Google Scholar 

  122. Muscatello L, Laccourreye O, Biacabe B, Hans S, Menard M, Brasnu D. Laryngofissure and cordectomy for glottic carcinoma limited to the mid third of the mobile true vocal cord. Laryngoscope. 1997;107(11 Pt 1):1507–10.

    Article  CAS  PubMed  Google Scholar 

  123. Liu C, Ward PH, Pleet L. Imbrication reconstruction following partial laryngectomy. Ann Otol Rhinol Laryngol. 1986;95(6 Pt 1):567–71.

    Article  CAS  PubMed  Google Scholar 

  124. Bailey BJ, Calcaterra TC. Vertical, subtotal laryngectomy and laryngoplasty. Review of experience. Arch Otolaryngol. 1971;93(3):232–7.

    Article  CAS  PubMed  Google Scholar 

  125. Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol. 1991;100(1):68–71.

    Article  CAS  PubMed  Google Scholar 

  126. Rothfield RE, Johnson JT, Myers EN, Wagner RL. The role of hemilaryngectomy in the management of T1 vocal cord cancer. Arch Otolaryngol Head Neck Surg. 1989;115(6):677–80.

    Article  CAS  PubMed  Google Scholar 

  127. Johnson JT, Myers EN, Hao SP, Wagner RL. Outcome of open surgical therapy for glottic carcinoma. Ann Otol Rhinol Laryngol. 1993;102(10):752–5.

    Article  CAS  PubMed  Google Scholar 

  128. Tufano RP, Stafford EM. Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am. 2008;41(4):741–55. vi.

    Google Scholar 

  129. Spaulding CA, Constable WC, Levine PA, Cantrell RW. Partial laryngectomy and radiotherapy for supraglottic cancer: a conservative approach. Ann Otol Rhinol Laryngol. 1989;98(2):125–9.

    Article  CAS  PubMed  Google Scholar 

  130. Lee NK, Goepfert H, Wendt CD. Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer Center experience with combined therapy. Laryngoscope. 1990;100(8):831–6.

    Article  CAS  PubMed  Google Scholar 

  131. Burstein FD, Calcaterra TC. Supraglottic laryngectomy: series report and analysis of results. Laryngoscope. 1985;95(7 Pt 1):833–6.

    CAS  PubMed  Google Scholar 

  132. Herranz-Gonzalez J, Gavilan J, Martinez-Vidal J, Gavilan C. Supraglottic laryngectomy: functional and oncologic results. Ann Otol Rhinol Laryngol. 1996;105(1):18–22.

    Article  CAS  PubMed  Google Scholar 

  133. Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol. 1997;18(6):385–90.

    Article  CAS  PubMed  Google Scholar 

  134. Kania R, Hans S, Garcia D, Brasnu D, De Mones E, Laccourreye O. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part II: incidence and consequences of local recurrence. Ann Otol Rhinol Laryngol. 2005;114(2):95–104.

    Article  PubMed  Google Scholar 

  135. Gallo A, Manciocco V, Simonelli M, Pagliuca G, D’Arcangelo E, de Vincentiis M. Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg. 2005;131(7):620–5.

    Article  PubMed  Google Scholar 

  136. Karasalihoglu AR, Yagiz R, Tas A, Uzun C, Adali MK, Koten M. Supracricoid partial laryngectomy with cricohyoidopexy and cricohyoidoepiglottopexy: functional and oncological results. J Laryngol Otol. 2004;118(9):671–5.

    Article  PubMed  Google Scholar 

  137. Sun DI, Cho KJ, Cho JH, Joo YH, Jung CK, Kim MS. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer. Clin Otolaryngol. 2009;34(2):132–9.

    Article  PubMed  Google Scholar 

  138. Laccourreye O, Ishoo E, de Mones E, Garcia D, Kania R, Hans S. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part I: technique, complications, and long-term functional outcome. Ann Otol Rhinol Laryngol. 2005;114(1 Pt 1):25–34.

    Article  PubMed  Google Scholar 

  139. Ganly I, Patel SG, Matsuo J, et al. Analysis of postoperative complications of open partial laryngectomy. Head Neck. 2009;31(3):338–45.

    Article  PubMed  Google Scholar 

  140. Byers RM. Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg. 1985;150(4):414–21.

    Article  CAS  PubMed  Google Scholar 

  141. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160(4):405–9.

    Article  CAS  PubMed  Google Scholar 

  142. Yang CY, Andersen PE, Everts EC, Cohen JI. Nodal disease in purely glottic carcinoma: is elective neck treatment worthwhile? Laryngoscope. 1998;108(7):1006–8.

    Article  CAS  PubMed  Google Scholar 

  143. Sjogren EV, van Rossum MA, Langeveld TP, et al. Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg. 2008;134(9):965–72.

    Article  PubMed  Google Scholar 

  144. Hirano M, Hirade Y, Kawasaki H. Vocal function following carbon dioxide laser surgery for glottic carcinoma. Ann Otol Rhinol Laryngol. 1985;94(3):232–5.

    CAS  PubMed  Google Scholar 

  145. McGuirt WF, Blalock D, Koufman JA, et al. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg. 1994;120(9):951–5.

    Article  CAS  PubMed  Google Scholar 

  146. Cohen SM, Garrett CG, Dupont WD, Ossoff RH, Courey MS. Voice-related quality of life in T1 glottic cancer: irradiation versus transoral endoscopic resection. Ann Otol Rhinol Laryngol. 2006;115(8):581–6.

    Article  PubMed  Google Scholar 

  147. Benninger MS, Gillen J, Thieme P, Jacobson B, Dragovich J. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope. 1994;104(3 Pt 1):294–8.

    CAS  PubMed  Google Scholar 

  148. Zeitels SM. Phonomicrosurgical treatment of early glottic cancer and carcinoma in situ. Am J Surg. 1996;172(6):704–9.

    Article  CAS  PubMed  Google Scholar 

  149. Ledda GP, Grover N, Pundir V, Masala E, Puxeddu R. Functional outcomes after CO2 laser treatment of early glottic carcinoma. Laryngoscope. 2006;116(6):1007–11.

    Article  PubMed  Google Scholar 

  150. Hutcheson KA, Barringer DA, Rosenthal DI, May AH, Roberts DB, Lewin JS. Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2008;134(2):178–83.

    Article  PubMed  Google Scholar 

  151. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24(17):2636–43.

    Article  PubMed  Google Scholar 

  152. Bernal-Sprekelsen M, Vilaseca-Gonzalez I, Blanch-Alejandro JL. Predictive values for aspiration after endoscopic laser resections of malignant tumors of the hypopharynx and larynx. Head Neck. 2004;26(2):103–10.

    Article  PubMed  Google Scholar 

  153. Jepsen MC, Gurushanthaiah D, Roy N, Smith ME, Gray SD, Davis RK. Voice, speech, and swallowing outcomes in laser treated laryngeal cancer. Laryngoscope. 2003;113(6):923–8.

    Article  PubMed  Google Scholar 

  154. Sasaki CT, Leder SB, Acton LM, Maune S. Comparison of the glottic closure reflex in traditional “open” versus endoscopic laser supraglottic laryngectomy. Ann Otol Rhinol Laryngol. 2006;115(2):93–6.

    Article  PubMed  Google Scholar 

  155. Rademaker AW, Logemann JA, Pauloski BR, et al. Recovery of postoperative swallowing in patients undergoing partial laryngectomy. Head Neck. 1993;15(4):325–34.

    Article  CAS  PubMed  Google Scholar 

  156. Farrag TY, Koch WM, Cummings CW, et al. Supracricoid laryngectomy outcomes: the Johns Hopkins experience. Laryngoscope. 2007;117(1):129–32.

    Article  PubMed  Google Scholar 

  157. Lallemant JG, Bonnin P, el-Sioufi I, Bousquet J. Cricohyoepiglot-topexy: long-term results in 55 patients. J Laryngol Otol. 1999;113(6):532–7.

    Google Scholar 

  158. Zacharek MA, Pasha R, Meleca RJ, et al. Functional outcomes after supracricoid laryngectomy. Laryngoscope. 2001;111(9):1558–64.

    Article  CAS  PubMed  Google Scholar 

  159. Lewin JS, Hutcheson KA, Barringer DA, et al. Functional analysis of swallowing outcomes after supracricoid partial laryngectomy. Head Neck. 2008;30(5):559–66.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1445, Houston, TX, 77030, USA

    Carol M. Lewis MD, MPH, Steven B. Chinn MD & Randal S. Weber MD

  2. Department of Head and Neck Surgery, Stamford University, Palo Alto, CA, USA

    Chris Holsinger MD

Authors
  1. Carol M. Lewis MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven B. Chinn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chris Holsinger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Randal S. Weber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carol M. Lewis MD, MPH .

Editor information

Editors and Affiliations

  1. Department of Radio-Oncology, Genolier Swiss Medical Network, Genolier, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lewis, C.M., Chinn, S.B., Holsinger, C., Weber, R.S. (2016). Cancers of the Larynx: Tis, T1, T2 Evaluation and Management. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27601-4_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27599-4

  • Online ISBN: 978-3-319-27601-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation